Published in Clin Transl Allergy on October 30, 2012
Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J (2014) 1.74
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med (2014) 0.86
Vitamin D and the development of allergic disease: how important is it? Clin Exp Allergy (2015) 0.86
The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med (2016) 0.85
Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days. World Allergy Organ J (2013) 0.83
Allergen-Specific Immunotherapy with Monomeric Allergoid in a Mouse Model of Atopic Dermatitis. PLoS One (2015) 0.80
Molecular biomarkers for grass pollen immunotherapy. World J Methodol (2014) 0.79
A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations. Clin Transl Allergy (2014) 0.78
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials? Curr Treat Options Allergy (2015) 0.78
Allergen immunotherapy on the way to product-based evaluation-a WAO statement. World Allergy Organ J (2015) 0.78
The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals. PLoS One (2015) 0.77
Escaping the trap of allergic rhinitis. Clin Mol Allergy (2015) 0.76
Clinical practice recommendations for allergen-specific immunotherapy in children: the Italian consensus report. Ital J Pediatr (2017) 0.75
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis. Biologics (2014) 0.75
Allergic Rhinitis and Chronic Daily Headaches: Is There a Link? Curr Neurol Neurosci Rep (2016) 0.75
The 11S globulin Sin a 2 from yellow mustard seeds shows IgE cross-reactivity with homologous counterparts from tree nuts and peanut. Clin Transl Allergy (2012) 0.75
Respiratory allergies: a general overview of remedies, delivery systems, and the need to progress. ISRN Allergy (2014) 0.75
Safety and efficacy of tree pollen specific immunotherapy on the ultrarush administration schedule method using purethal trees. Biomed Res Int (2014) 0.75
Therapeutic interventions in severe asthma. World Allergy Organ J (2016) 0.75
Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus. Allergy Asthma Clin Immunol (2013) 0.75
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy (2008) 12.35
Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10
Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med (1999) 5.46
Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2007) 4.67
The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol (2008) 3.90
Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol (1998) 3.27
Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy (2004) 2.93
Time trends in allergic disorders in the UK. Thorax (2006) 2.83
Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy (2009) 2.81
Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev (2007) 2.77
Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet (2006) 2.63
Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev (2010) 2.53
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol (2012) 2.28
Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol (2004) 2.15
Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev (2010) 2.10
Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy (2007) 2.10
Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol (2007) 1.84
Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy (2011) 1.71
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol (2010) 1.55
Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol (2005) 1.52
The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics (2004) 1.31
Epidemiology and disease burden from allergic disease in Scotland: analyses of national databases. J R Soc Med (2009) 1.30
Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol (2010) 1.27
Quality-of-life and asthma-severity in general population asthmatics: results of the ECRHS II study. Allergy (2008) 1.26
ARIA update: I--Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol (2006) 1.26
Establishing the incidence and prevalence of clinician-diagnosed allergic conditions in children and adolescents using routinely collected data from general practices. Clin Exp Allergy (2009) 1.18
Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol (2004) 1.16
Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy (2006) 1.14
Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol (2010) 1.06
The allergy epidemic extends beyond the past few decades. Clin Exp Allergy (2004) 1.06
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. Allergy (2008) 1.05
Trends in prevalence of asthma, allergic rhinitis and atopic dermatitis in 5-7-year old Swiss children from 1992 to 2001. Allergy (2006) 1.03
The socio-economic burden of asthma is substantial in Europe. Allergy (2008) 0.99
Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients--an observational, cross sectional study in four countries in Europe. J Med Econ (2011) 0.99
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol (2004) 0.98
One hundred years of allergen immunotherapy European Academy of Allergy and Clinical Immunology celebration: review of unanswered questions. Allergy (2012) 0.96
An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy (2008) 0.95
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Maternal depression related to infant's wheezing. Pediatr Allergy Immunol (2011) 0.95
Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr (2006) 0.91
Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy? Clin Exp Allergy (1998) 0.91
Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy (2005) 0.90
Dimensions of respiratory symptoms in preschool children: population-based birth cohort study. Am J Respir Crit Care Med (2008) 0.88
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy (2012) 0.87
Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis. Clin Exp Allergy (2011) 0.86
Cost-effectiveness of specific immunotherapy with Grazax in allergic rhinitis co-existing with asthma. Allergy (2008) 0.86
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article. J Allergy Clin Immunol (2010) 0.84
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England. Drug Saf (2006) 0.84
Allergen avoidance in the secondary and tertiary prevention of allergic diseases: does it work? Prim Care Respir J (2006) 0.82
Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. Ann Allergy Asthma Immunol (2010) 0.81
Advances in allergen-specific immunotherapy. Curr Drug Targets (2009) 0.78
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature (2007) 14.43
Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med (2002) 9.14
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med (2004) 8.39
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ (2008) 7.60
Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet (2005) 6.86
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol (2006) 6.64
Tiotropium Respimat inhaler and the risk of death in COPD. N Engl J Med (2013) 6.36
Withdrawal of inhaled glucocorticoids and exacerbations of COPD. N Engl J Med (2014) 6.29
The impact of eHealth on the quality and safety of health care: a systematic overview. PLoS Med (2011) 6.23
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol (2004) 5.80
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol (2010) 5.80
Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med (2012) 5.64
Illness trajectories and palliative care. BMJ (2005) 5.19
Developing primary palliative care. BMJ (2004) 5.08
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
The Norway spruce genome sequence and conifer genome evolution. Nature (2013) 4.74
Telephone consultations. BMJ (2003) 4.25
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 4.10
Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles (2013) 4.05
Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med (2003) 4.00
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet (2012) 3.93
Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med (2008) 3.90
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol (2002) 3.71
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ (2009) 3.68
Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ (2011) 3.61
Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49
Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med (2005) 3.48
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry (2006) 3.38
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol (2012) 3.23
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Internet-based interventions for smoking cessation. Cochrane Database Syst Rev (2010) 3.15
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 3.08
Can we systematically review studies that evaluate complex interventions? PLoS Med (2009) 3.04
Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med (2011) 3.03
Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med (2006) 3.00
Accessibility, acceptability, and effectiveness in primary care of routine telephone review of asthma: pragmatic, randomised controlled trial. BMJ (2003) 2.93
Scanning the genome for gene single nucleotide polymorphisms involved in adaptive population differentiation in white spruce. Mol Ecol (2008) 2.91
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol (2006) 2.85
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet (2006) 2.81
Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey. BMJ (2002) 2.81
Enhancing public safety in primary care. BMJ (2002) 2.80
Evaluating eHealth interventions: the need for continuous systemic evaluation. PLoS Med (2009) 2.73
Email consultations in health care: 2--acceptability and safe application. BMJ (2004) 2.72
Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ (2009) 2.72
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol (2004) 2.69
Rhinitis and onset of asthma: a longitudinal population-based study. Lancet (2008) 2.68
Prescribing safety features of general practice computer systems: evaluation using simulated test cases. BMJ (2004) 2.67
Palliative care in chronic illness. BMJ (2005) 2.66
ICON: food allergy. J Allergy Clin Immunol (2012) 2.65
A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am J Respir Crit Care Med (2009) 2.56
Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics (2005) 2.56
Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med (2010) 2.56
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet (2008) 2.53
Email consultations in health care: 1--scope and effectiveness. BMJ (2004) 2.50
Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol (2003) 2.50
Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol (2010) 2.50
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int (2014) 2.47
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. N Engl J Med (2015) 2.44
Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol (2005) 2.44
Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol (2008) 2.42
Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol (2004) 2.40
Clinical decision support systems could be modified to reduce 'alert fatigue' while still minimizing the risk of litigation. Health Aff (Millwood) (2011) 2.32
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. J Allergy Clin Immunol (2011) 2.29
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol (2012) 2.28
Early identification of atopy in the prediction of persistent asthma in children. Lancet (2008) 2.27
Eosinophilia and diseases: clinical revision of 1862 cases. Arch Intern Med (2003) 2.26
World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J (2011) 2.24
The case study approach. BMC Med Res Methodol (2011) 2.23
Role of contact sensitization in chronic urticaria. J Am Acad Dermatol (2006) 2.22
Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir Med (2009) 2.22
Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med (2007) 2.21
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol (2010) 2.19
Assembling the 20 Gb white spruce (Picea glauca) genome from whole-genome shotgun sequencing data. Bioinformatics (2013) 2.18
World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol (2011) 2.16
Isolation and characterization of RNA-containing exosomes. J Vis Exp (2012) 2.16
Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med (2002) 2.14
Delay in diagnosis of lung cancer in general practice. Br J Gen Pract (2006) 2.12
CCDC39 is required for assembly of inner dynein arms and the dynein regulatory complex and for normal ciliary motility in humans and dogs. Nat Genet (2010) 2.12
Methylene blue-treated plasma: an increased allergy risk? J Allergy Clin Immunol (2012) 2.11
The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol (2005) 2.11
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Use of serial qualitative interviews to understand patients' evolving experiences and needs. BMJ (2009) 2.09